Evaxion A (EVAX) EPS (Basic) (2020 - 2026)
Evaxion A (EVAX) reported EPS (Basic) of -$0.0 for Q1 2026, down 52.19% on a YoY basis from -$0.0 in Q1 2025, and up 97.68% quarter-over-quarter from -$0.0 in Q4 2025.
Evaxion A (EVAX) EPS (Basic) (2020 - 2026) Analysis & Trends
Evaxion A has reported EPS (Basic) for 7 years, with the latest figure at -$0.0 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 52.19% year-over-year to -$0.0; the trailing twelve-month figure through Mar 2026 stood at $461800.0 (up 994.09% YoY), and the FY2025 full-year result was -$0.02, up 90.0% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.0, up from -$0.0 in the prior quarter.
- The five-year high for EPS (Basic) was $461800.0 in Q3 2025, with the low at -$51650.0 in Q2 2024.
- Historically, EPS (Basic) has averaged $25117.6 across 5 years, with a median of -$0.0 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 486658940.92% — and 2025, when it jumped 1318703407448.84%.
- Evaxion A's EPS (Basic) stood at -$0.29 in 2022, then soared by 58.95% to -$0.12 in 2023, then tumbled by 189.15% to -$0.35 in 2024, then surged by 99.89% to -$0.0 in 2025, then surged by 97.68% to -$0.0 in 2026.
- The last three EPS (Basic) figures came in at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and $461800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 461,800.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.35 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -51,650.00 |
| Mar 31, 2024 | 39,800.00 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -12,354.35 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -10,595.56 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |